ask="6.15"
ask_size="1000"
average_daily_volume="1448160"
bid="5.91"
bid_size="200"
book_value="-0.08"
change="+0.30"
change_from_200_day_moving_average="0.52"
change_from_50_day_moving_average="0.62"
change_from_52_week_high="-1.97"
change_From_52_week_low="1.80"
change_in_percent="+5.42%"
close="5.83"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.52"
ebitda="-121.76M"
eps_estimate_current_year="-0.67"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.27"
ex_dividend_date="N/A"
float_shares="72994000"
high="5.87"
high_52_weeks="7.80"
last_trade_date="3/17/2017"
last_trade_price="5.83"
last_trade_size="397022"
last_trade_time="4:00pm"
low="5.49"
low_52_weeks="4.03"
market_capitalization="627.70M"
moving_average_200_day="5.31"
moving_average_50_day="5.21"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.00"
open="5.49"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+9.70%"
percent_change_from_50_day_moving_average="+11.81%"
percent_change_from_52_week_high="-25.26%"
percent_change_from_52_week_low="+44.67%"
previous_close="5.53"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="18.62"
revenue="31.98M"
shares_outstanding="107667000"
short_ratio="15.22"
stock_exchange="NCM"
symbol="KERX"
volume="3057151"
weeks_range_52="4.03 - 7.80"
